Articles

Why record cash in money-market funds won’t necessarily flood into stocks, bonds

The record amount of cash in money-market funds isn’t about to flood into riskier assets in the stock and bond markets — despite the Federal Reserve recently resuming its interest-rate-cutting cycle, according to research from J.P. Morgan.

Trump rolls out his latest deal with a drugmaker. This one stems from his campaign promise to cover all IVF costs.

President Donald Trump on Thursday announced a deal with EMD Serono, a subsidiary of German drugmaker Merck KGaA, that aims to cut the out-of-pocket costs for in vitro fertilization, with the move coming more than a year after his campaign promise to eliminate all such costs for the fertility treatment.

Lithium Americas is deemed vital by Trump, but investors beware, J.P. Morgan says

Lithium Americas Corp. saw its stock surge recently after the federal government took a stake in the company, but J.P. Morgan warns that investors should not get carried away with the the lithium producer’s newfound popularity in Washington.

Oracle’s stock rises as Wall Street’s AI profitability concerns are put to rest

The tech giant raised its long-term financial targets and projected strong cloud margins, reassuring investors that its massive AI spending spree is on a path to profitability

Gold is the hot topic at the IMF and World Bank meetings. Could that help put a lid on prices?

The record price of gold is the “topic du jour” among the finance elite.

Jerome Powell may have just given stock investors a new reason to be worried

The Fed plans to end its quantitative-tightening program — but stocks do better under those conditions.

Spotify says it’s working to protect artists from AI abuse, but the streaming company’s track record is shaky

After years of fighting scams and fraud, the music-streaming company announced it is joining forces with three major music labels to develop AI products that can help artists.

U.S. runs another huge budget deficit in 2025 — and the national debt hits another record

The U.S. government ran a slightly smaller budget shortfall in the most recent year thanks to higher tariff revenue — but the national debt still rose to another record high, and shows no sign of slowing.

Official data dramatically underestimates hedge funds’ involvement in the Treasury market, Fed paper finds

Key Treasury Department data is massively underreporting the amount of U.S. government debt held by hedge funds registered and incorporated in the Cayman Islands, and is failing to reflect their heavy reliance on a controversial leveraged trade that has repeatedly alarmed regulators.

Praxis Precision’s tremor-drug trial succeeds where others have failed. The stock is skyrocketing.

Shares of Praxis Precision Medicines have hit their highest intraday level since March 2022.

‘Sell’ signs are showing up in the stock market — but this number matters most

The S&P 500 can climb a ‘wall of worry’ — if it stays above 6,500.

Zions takes $50 million loan loss as another credit ‘cockroach’ appears. Its stock is falling.

Analyst cuts price target for regional bank’s shares as it discloses loan losses, days after JPMorgan Chase CEO Jamie Dimon warned of credit-market conditions.
1 63 64 65 66 67 2,431